Drug Approval | March 09, 2023
Alembic receives USFDA final approval for Prazosin Hydrochloride Capsules
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Rocuronium Bromide Injection is a neuromuscular blocking agent
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
he product will be launched shortly in the US market.
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Subscribe To Our Newsletter & Stay Updated
